StockData

agilon health vs Sotera Health

AGL and SHC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AGL and SHC compare

Sotera Health is the larger company, worth 2.4 times as much as agilon health ($4.6B against $2.0B).

Sotera Health grew revenue faster over the last twelve months (8.1% versus 0.32% for agilon health).

Sotera Health keeps more of each dollar of sales as profit, with a net margin of 13.4% compared with −3.9% at agilon health.

Sotera Health scores higher on the StockData Score (7 against 4 for agilon health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAGLSHC
Size and price
Market cap$2.0B$4.6B
Share price$116.75$16.25
Change, 1 year675%1.5%
Change, 5 years−78.4%−25.0%
Beta (5Y)5.391.58
Employees8563,000
StockData Score
Total score47 (better)
Valuation score11
Growth score11
Performance score13 (better)
Health score12 (better)
Dividend score00
Valuation
P/E–28.5×
P/S0.3× (better)3.8×
P/B–7.0×
P/FCF–41.1×
FCF yield−4.3%2.4% (better)
Growth
Revenue growth (TTM)0.32%8.1% (better)
Revenue growth, 5Y average37.2% (better)7.3%
Net income growth (TTM)–581%
EPS growth (TTM)–613%
Profitability
Gross margin–55.0%
Operating margin−5.2%–
Net margin−3.9%13.4% (better)
FCF margin−1.4%9.3% (better)
Return on equity–27.8%
Financial health
Debt / equity–3.21
Interest coverage−44.4×–
Current ratio1.082.80 (better)
Altman Z-score2.34 (better)1.38
Piotroski F-score27 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions95.8%103%
Held by insiders10.1%–
Insider net buying, 12 months$300K (better)−$1.8B
Superinvestors holding11
Short interest, % of float5.6%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.